Mouse Recombinant IL2 protein (V2LY-0526-LY8512)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
E. coli
Protein Species
Mouse
Protein Construction
This product is Mouse Recombinant IL2 protein consist of Amino Acid: 21-169 and predicts a molecular mass of 17.4 kDa.
Molecule Mass
17.4 kDa
Sequence
Amino Acid: 21-169
Species
Mouse

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
>92% as determined by SDS-PAGE
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
Interleukin 2
Alternative Names
Interleukin 2
Function
Produced by T-cells in response to antigenic or mitogenic stimulation, this protein is required for T-cell proliferation and other activities crucial to regulation of the immune response. Can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells.
Cellular Location
Secreted
Involvement in disease
A chromosomal aberration involving IL2 is found in a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(4;16)(q26;p13) with involves TNFRSF17.

Liu, Y., Zhou, N., Zhou, L., Wang, J., Zhou, Y., Zhang, T., ... & Huang, B. (2021). IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor. Nature immunology, 22(3), 358-369.

Lopes, J. E., Fisher, J. L., Flick, H. L., Wang, C., Sun, L., Ernstoff, M. S., ... & Losey, H. C. (2020). ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. Journal for immunotherapy of cancer, 8(1).

Damoiseaux, J. (2020). The IL-2–IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor. Clinical Immunology, 218, 108515.

Papillion, A., Powell, M. D., Chisolm, D. A., Bachus, H., Fuller, M. J., Weinmann, A. S., ... & Ballesteros-Tato, A. (2019). Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells. Science immunology, 4(39), eaaw7636.

Forsberg, E. M., Lindberg, M. F., Jespersen, H., Alsén, S., Bagge, R. O., Donia, M., ... & Nilsson, J. A. (2019). HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy–resistant human melanoma in IL2 transgenic NOD/SCID IL2 receptor knockout mice. Cancer Research, 79(5), 899-904.

Mortara, L., Balza, E., Bruno, A., Poggi, A., Orecchia, P., & Carnemolla, B. (2018). Anti-cancer therapies employing IL-2 cytokine tumor targeting: contribution of innate, adaptive and immunosuppressive cells in the anti-tumor efficacy. Frontiers in Immunology, 9, 2905.

Abbas, A. K., Trotta, E., R. Simeonov, D., Marson, A., & Bluestone, J. A. (2018). Revisiting IL-2: Biology and therapeutic prospects. Science immunology, 3(25), eaat1482.

Sockolosky, J. T., Trotta, E., Parisi, G., Picton, L., Su, L. L., Le, A. C., ... & Garcia, K. C. (2018). Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science, 359(6379), 1037-1042.

Fan, M. Y., Low, J. S., Tanimine, N., Finn, K. K., Priyadharshini, B., Germana, S. K., ... & Turka, L. A. (2018). Differential roles of IL-2 signaling in developing versus mature Tregs. Cell reports, 25(5), 1204-1213.

DiToro, D., Winstead, C. J., Pham, D., Witte, S., Andargachew, R., Singer, J. R., ... & Weaver, C. T. (2018). Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells. Science, 361(6407), eaao2933.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Recombinant IL2 protein?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.